A small sized pharmaceutical company was approaching the final phases of a large phase III study. The criteria that required the client to provide study medication to patients active at the conclusion of the study until the drug would be commercially available. The company called upon a clinical supplies management (CSM) team to support the study during this final phase to avoid serious drug supply issues and potential “out of stock” situations with patients not being able to continue their treatment.
As the nature of the target molecule becomes increasingly challenging, the need is to move away from the current linear and siloed drug development approach. This customized and multidisciplinary platform can identify the most suitable drug delivery technology during early-stage drug development, reduce potential risks, and contribute to overall time and cost savings.
There are special clinical packaging, logistics and import/export considerations that should be taken into account when developing a clinical supply strategy in China, Singapore and Japan. Explore how to leverage the major clinical supply centers of in these countries to support clinical trials within the Asia-Pacific region for both local and global study sponsors.
You need a global distribution network that can deliver what you need, where you need it and when you need it. Catalent in-house pharmaceutical sourcing specialists utilize a global network of leading manufacturers, wholesalers, and carefully selected QA-qualified healthcare professionals to provide cost-effective access to virtually any product.